| NEB altered in cohorts of …ALTERED_INderived23 of 23show fewer |
|---|
| → altered in cohorts of | Skin Squamous Cell Carcinoma 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Basal Cell Carcinoma 55 / 126 cases (44 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 42 / 144 cases (29 %) · ssm · mel_dfci_2019 · largest of 2 cohorts | — | — | Melanoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 104 / 469 cases (22 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 106 / 517 cases (21 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 26 / 134 cases (19 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 29 / 158 cases (18 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 123 / 755 cases (16 %) · ssm · mbn_mdacc_2013 | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 37 / 247 cases (15 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 62 / 429 cases (14 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 69 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 153 / 1,144 cases (13 %) · ssm · nsclc_tcga_broad_2016 · largest of 2 cohorts | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 71 / 566 cases (13 %) · ssm · luad_tcga_pan_can_atlas_2018 · largest of 7 cohorts | — | — | Lung Adenocarcinoma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 61 / 518 cases (12 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 21 / 185 cases (11 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 48 / 478 cases (10 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 97 / 1,015 cases (9.6 %) · ssm · crc_sysucc_2022 · largest of 3 cohorts | — | — | Colorectal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 45 / 474 cases (9.5 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 26 / 291 cases (8.9 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 51 / 629 cases (8.1 %) · ssm · difg_glass · largest of 3 cohorts | — | — | Diffuse Glioma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 34 / 515 cases (6.6 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 32 / 494 cases (6.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 24 / 417 cases (5.8 %) · ssm · chol_icgc_2017 | — | — | Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |